Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-14

Clinical Trial Update: To Discuss the Best Mode for Taking Lapatinib Under the Influence of the Diet [NA]

View source ↗

Summary

A clinical trial update discussing the best method for taking the breast cancer drug lapatinib in relation to diet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tykerb (lapatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | NA | Status: UNKNOWN